| Subject: | FDA Announces Class I Recall of Bayer Ascensia Contour Blood Glucose Monitoring System |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Mon, 16 Jul 2007 - 12:00 pm |
| Audience: Endocrinologists, healthcare professionals, diabetic patients, and pharmacies Bayer Healthcare and the FDA are notifying healthcare professionals and consumers of a Class I recall of Bayer Ascensia Contour Blood Glucose Monitoring System, Product 7152A. The system consists of a meter, test strips contained in a dry (desiccated) bottle, a bottle of test solution, a lancing device and lancets, and instructions for use. The meters were distributed from March 23, 2007... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
External Links:
|
|
StayAlert! provides immediate notification of regulatory body legislation impacting the healthcare industry, helping you to meet regulatory compliance. Subscribers are notified of any new or revised regulations, provided with a summary of the regulation, followed by an implementation action plan and/or policy. Designed as an e-mail "push" method for rapid customer notification of healthcare compliance issues, paired with interpretative analysis and practical application, the StayAlert!® Virtual Compliance Administrator™ saves you time and money. Other vendors have components of legislated requirements available online or on CD-ROM. However there is no other product that marries regulatory agency mandates with implementation tools, making the latest compliance information immediately available online. No other product provides an interpretative analysis, followed by a practical application tool, therefore providing users with an immediate solution to compliance problems. StayAlert! includes operational components for healthcare organizations, allowing complete facility compliance with mandated requirements, online. |
|
